Revvity Cash Flow Statement
RVTY / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Revvity generated $583M in operating cash flow and $509M in free cash flow in FY2025. Free cash flow margin was 17.8% of revenue.
Based on SEC 10-K filings.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $241.2M | $270.4M | $693.1M | $569.2M | $943.2M | $727.9M | $227.6M | $237.9M | $292.6M | $234.3M | $212.4M | $157.8M | $167.2M | $69.9M | $7.7M |
| Depreciation & Amortization | $405.3M | $427.8M | $431.8M | $427.0M | $311.4M | $201.6M | $214.0M | $180.6M | $105.0M | $100.0M | $105.4M | $110.5M | $126.9M | $125.1M | $110.9M |
| Operating Cash Flow | $582.9M | $628.3M | $91.3M | $679.8M | $1.4B | $892.2M | $363.5M | $311.0M | $288.5M | $350.6M | $287.1M | $281.6M | $158.6M | $152.2M | $224.9M |
| Capital Expenditures | $73.5M | $86.6M | $81.4M | $85.6M | $86.0M | $63.6M | $76.3M | $93.3M | $39.1M | $31.7M | $28.2M | $27.2M | $39.0M | $42.4M | $30.6M |
| Free Cash Flow | $509.4M | $541.7M | $9.9M | $594.2M | $1.3B | $828.5M | $287.1M | $217.8M | $249.4M | $318.9M | $258.9M | $254.4M | $119.6M | $109.8M | $194.3M |
| Share Buybacks | $820.8M | $369.6M | $388.9M | $80.6M | $73.1M | $6.9M | $6.3M | $57.4M | $3.8M | $151.8M | $76.4M | $65.5M | $127.4M | $2.1M | $110.0M |
| Dividends Paid | $32.8M | $34.5M | $35.0M | $35.3M | $32.4M | $31.2M | $31.1M | $31.0M | $30.8M | $30.8M | $31.6M | $31.6M | $31.6M | $31.9M | $31.8M |
| FCF Margin | 17.8% | 19.7% | 0.4% | 17.9% | 34.6% | 21.9% | 10.0% | 7.8% | 11.1% | 59.5% | 12.3% | 11.4% | 5.5% | 5.2% | 10.1% |